stoxline Quote Chart Rank Option Currency Glossary
  
Orthofix Medical Inc. (OFIX)
14.22  -0.23 (-1.59%)    05-30 16:00
Open: 14.59
High: 14.675
Volume: 161,970
  
Pre. Close: 14.45
Low: 14.17
Market Cap: 534(M)
Technical analysis
2024-05-30 4:43:30 PM
Short term     
Mid term     
Targets 6-month :  17.07 1-year :  18.53
Resists First :  14.61 Second :  15.86
Pivot price 14.8
Supports First :  12.59 Second :  10.47
MAs MA(5) :  14.6 MA(20) :  14.55
MA(100) :  13.92 MA(250) :  14.79
MACD MACD :  0.2 Signal :  0.2
%K %D K(14,3) :  26.4 D(3) :  47.4
RSI RSI(14): 47.9
52-week High :  21.6 Low :  9.56
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ OFIX ] has closed above bottom band by 4.3%. Bollinger Bands are 28.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 14.71 - 14.79 14.79 - 14.86
Low: 13.96 - 14.08 14.08 - 14.16
Close: 14.07 - 14.24 14.24 - 14.37
Company Description

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Headline News

Tue, 28 May 2024
17740 Shares in Orthofix Medical Inc. (NASDAQ:OFIX) Purchased by Dynamic Technology Lab Private Ltd - Defense World

Sun, 26 May 2024
Orthofix (OFIX) Q3 Earnings and Revenues Top Estimates - Yahoo New Zealand News

Sat, 25 May 2024
Amalgamated Bank Reduces Stock Position in Orthofix Medical Inc. (NASDAQ:OFIX) - Defense World

Mon, 20 May 2024
Boston Partners Cuts Holdings in Orthofix Medical Inc. (NASDAQ:OFIX) - Defense World

Thu, 09 May 2024
Orthofix gets FDA clearance for Rodeo Telescopic Nail (NASDAQ:OFIX) - Seeking Alpha

Thu, 09 May 2024
Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail - OrthoSpineNews

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 38 (M)
Shares Float 26 (M)
Held by Insiders 3.5 (%)
Held by Institutions 94.3 (%)
Shares Short 4,050 (K)
Shares Short P.Month 3,840 (K)
Stock Financials
EPS -3.36
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 15.23
Profit Margin -16.7 %
Operating Margin -16.2 %
Return on Assets (ttm) -2.8 %
Return on Equity (ttm) -20.5 %
Qtrly Rev. Growth 7.6 %
Gross Profit (p.s.) 0
Sales Per Share 20.25
EBITDA (p.s.) 0.58
Qtrly Earnings Growth 0 %
Operating Cash Flow -30 (M)
Levered Free Cash Flow -1 (M)
Stock Valuations
PE Ratio -4.24
PEG Ratio -2.8
Price to Book value 0.93
Price to Sales 0.7
Price to Cash Flow -17.6
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android